Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.

Privia Health Group Inc is a technology-driven, national physician-enablement company. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve ...

U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or ...

Labcorp Holdings Inc. LH, or Labcorp, is slated to report its first-quarter 2025 results on April 29, before the opening bell ...

Telehealth providers, whose revenue skyrocketed amidst GLP-1 shortages, remain defiant on their compounded semaglutide ...

Hims & Hers Health, Inc.’s HIMS investors have been experiencing some short-term gains from the stock of late, which are much ...

HIMS has experienced similar dramatic drops before. During the 2022 inflation surge, the stock fell 87%, and in 2020, it ...

Veterinary telehealth company Dutch is highlighting an overall lack of vet care options for pet owners nationwide.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

We will be sharing Q1 2025 hedge fund investor letters in this article. You can also see the hedge fund investor letters for 2024 Q4, 2024 Q3, 2024 Q2 , 2024 Q1, 2023 Q4, 2023 Q3 and 2023 Q2 by ...

JetBlue Airways Corporation announced today that it will hold its quarterly conference call to discuss first quarter 2025 financial results on April 29th, 2025 at 10:00 a.m. ET. A live, listen-only ...

Hims & Hers Health, Inc. is anticipated to report earnings per share (EPS) of $0.11 for the current quarter, reflecting a substantial 120% increase from the same period last year. Revenue is projected ...